SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10794	Companies
233203	Keywords
161797	Articles
124399	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 04/07/2026 at 07:00, 3 months 26 days ago

Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
Sanofi's lunsekimig meets primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP, showing promising results for managing respiratory diseases

Respiratory Diseases Sanofi Asthma Lunsekimig Phase 2 Studies
BRIEF

published on 03/28/2026 at 16:05, 4 months 5 days ago

Sanofi's Amlitelimab Shows Promising Results in Phase 3 Atopic Dermatitis Studies

Clinical Development Sanofi Atopic Dermatitis Phase 3 Studies Amlitelimab
PRESS RELEASE

published on 03/28/2026 at 16:00, 4 months 5 days ago

Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
Positive results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented at AAD Annual Meeting, showing progressive efficacy with Q12W dosing potential

Sanofi Phase 3 Atopic Dermatitis Amlitelimab Q12W
BRIEF

published on 03/27/2026 at 13:05, 4 months 6 days ago

Sanofi: EU approval recommended for subcutaneous Sarclisa

Sanofi Multiple Myeloma Sarclisa CHAMP Portable Injector
BRIEF

published on 03/27/2026 at 13:05, 4 months 6 days ago

Sanofi's Sarclisa SC Recommended for EU Approval

Sanofi Multiple Myeloma EU Approval Sarclisa SC On-Body Injector
PRESS RELEASE

published on 03/27/2026 at 13:00, 4 months 6 days ago

Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
Sanofi's Sarclisa subcutaneous formulation via on-body injector recommended for EU approval by CHMP for multiple myeloma treatment, offering innovative delivery. Final decision expected soon

Multiple Myeloma Sarclisa CHMP Recommendation On-Body Injector Subcutaneous Formulation
BRIEF

published on 03/24/2026 at 07:35, 4 months 9 days ago

Sanofi's Q1 2026 financial guide is now online

Investors Quarterly Results Sanofi Financial Document Q1 2026
BRIEF

published on 03/24/2026 at 07:35, 4 months 9 days ago

Sanofi Releases Q1 2026 Aide-Mémoire to Support Financial Analysis

Innovation Biopharma Sanofi Financial Modeling Q1 2026 Results
PRESS RELEASE

published on 03/24/2026 at 07:30, 4 months 9 days ago

Press release: Availability of the Q1 2026 aide-mémoire
Sanofi announces availability of Q1 2026 aide-mémoire for financial modelling purposes. Details on non-comparable items, currency impact, and share count included. Results to be published on April 23, 2026

Sanofi Results Aide-mémoire Financial Modelling Q1 2026
BRIEF

published on 03/18/2026 at 07:05, 4 months 16 days ago

Sanofi's Venglustat Earns Breakthrough Therapy Designation for Gaucher Disease Type 3

FDA Sanofi Breakthrough Therapy Venglustat Gaucher Disease

Accesswire

Published on 08/01/2026 at 01:20, 2 days 6 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 6 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 6 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 2 days 7 hours ago

BioNxt Solutions Announces Option Grants
Published on 07/31/2026 at 23:20, 2 days 8 hours ago

Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.

View all ACCESSWIRE

EQS Group

Published on 08/03/2026 at 07:00, 27 minutes ago

Sandoz takes further steps to resolve legacy US generic medicine litigation
Published on 08/03/2026 at 07:00, 27 minutes ago

Stabilus SE: Adjusted EBIT margin increased in Q3 FY2026 despite a decline in revenue – sale of Fabreeka and Tech Products completed and net debt further reduced
Published on 08/03/2026 at 07:00, 27 minutes ago

AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland AG continues to grow and outperforms the Swiss hotel market in the first half of 2026
Published on 08/03/2026 at 06:45, 42 minutes ago

HDBank secures record international syndicated social loan in Vietnam
Published on 08/03/2026 at 06:30, 57 minutes ago

HDBank posts 31% rise in first-half profit, assets exceed VND1 quadrillion

Les Echos

Published on 08/03/2026 at 07:00, 27 minutes ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 07/31/2026 at 21:00, 2 days 10 hours ago

Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 12 hours ago

Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:14, 2 days 12 hours ago

2026 First-Half financial report
Published on 07/31/2026 at 19:13, 2 days 12 hours ago

Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026

View all LES ECHOS COMFI WIRE